<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="ko" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJORL</journal-id>
<journal-title-group>
<journal-title>Korean Journal of Otorhinolaryngology-Head and Neck Surgery</journal-title><abbrev-journal-title>Korean J Otorhinolaryngol-Head Neck Surg</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">2092-5859</issn>
<issn pub-type="epub">2092-6529</issn>
<publisher>
<publisher-name>Korean Society of Otolaryngology-Head and Neck Surgery</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3342/kjorl-hns.2021.00892</article-id>
<article-id pub-id-type="publisher-id">kjorl-hns-2021-00892</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
<subj-group subj-group-type="heading">
<subject>Otology</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>NAL-NL2 보청기 처방 공식 이득값과 한국인의 선호 이득값의 차이</article-title>
<trans-title-group>
<trans-title xml:lang="en">Difference Between the Preferred Gain and the NAL-NL2 Gain in Korean Hearing Aid Users</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8138-969X</contrib-id>
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Jong-Geun</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>이</surname><given-names>종근</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjorl-hns-2021-00892"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7900-1991</contrib-id>
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Jeon</surname><given-names>Jae-Min</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>전</surname><given-names>재민</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjorl-hns-2021-00892"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8488-9091</contrib-id>
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Song</surname><given-names>Jae-Jun</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>송</surname><given-names>재준</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjorl-hns-2021-00892"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6401-352X</contrib-id>
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Chae</surname><given-names>Sung-Won</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>채</surname><given-names>성원</given-names></name>
</name-alternatives>
<xref ref-type="corresp" rid="c1-kjorl-hns-2021-00892"/>
<xref ref-type="aff" rid="af1-kjorl-hns-2021-00892"/>
</contrib>
<aff-alternatives id="af1-kjorl-hns-2021-00892">
<aff xml:lang="en">Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, <country>Korea</country></aff>
<aff xml:lang="ko">고려대학교 의과대학 이비인후-두경부외과학교실</aff>
</aff-alternatives>
</contrib-group>
<author-notes>
<corresp id="c1-kjorl-hns-2021-00892">Address for correspondence Sung-Won Chae, MD, PhD Department of Otorhinolaryngology-Head and Neck surgery, Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea Tel +82-2-2626-3186 Fax +82-2-868-0475 E-mail <email>koreachae@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>07</month>
<year>2022</year></pub-date>
<pub-date pub-type="epub">
<day>7</day>
<month>6</month>
<year>2022</year></pub-date>
<volume>65</volume>
<issue>7</issue>
<fpage>381</fpage>
<lpage>385</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>9</month>
<year>2021</year></date>
<date date-type="rev-recd">
<day>2</day>
<month>12</month>
<year>2021</year></date>
<date date-type="accepted">
<day>10</day>
<month>12</month>
<year>2021</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000a9; 2022 Korean Society of Otorhinolaryngology-Head and Neck Surgery</copyright-statement>
<copyright-year>2022</copyright-year>
<license>
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<trans-abstract xml:lang="en">
<sec><title>Background and Objectives</title>
<p>The purpose of this study was to compare the preferred gain and the National Acoustic Laboratories Nonlinear 2nd edition (NAL-NL2) gain value in Korean language hearing aid users.</p></sec>
<sec><title>Subjects and Method</title>
<p>In this retrospective study, preferred gain and NAL-NL2 gain data were obtained from 199 monaural hearing aids users who were satisfied with their hearing aid devices. The gain value data were collected from three different sound levels at various frequencies. Several factors were also evaluated to determine a potential impact on the preferred gain.</p></sec>
<sec><title>Results</title>
<p>The preferred gain was significantly higher than the NAL-NL2 target gain (<italic>p</italic>&#x0003d;0.01). This difference was highest with the gain measured with a medium-level sound (65 dB) with 1 kHz tone. There was a tendency of reduced preferred gain with the increased age of the participant (<italic>p</italic>&#x0003d;0.049).</p></sec>
<sec><title>Conclusion</title>
<p>The results indicate that Korean hearing aid users require more gain than the NAL-NL2 target gain. Linguistic characteristics, age, degree of hearing loss, and many other factors may be implicated in this result.</p></sec>
</trans-abstract>
<kwd-group xml:lang="en">
<kwd>Audiologic rehabilitation</kwd>
<kwd>Hearing aids</kwd>
<kwd>Hearing loss</kwd>
<kwd>Prescription</kwd>
</kwd-group>
</article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Hearing aids amplify the input signal to compensate for the increased hearing threshold of the hearing loss (HL) patient. The principle of fitting a hearing aid is that the amplified sound should be comfortably heard by the HL patient, and the intelligibility should be increased during conversation. The volume of the amplified sound should be adjusted so that it does not exceed the uncomfortable level &#x0005b;<xref ref-type="bibr" rid="b1-kjorl-hns-2021-00892">1</xref>,<xref ref-type="bibr" rid="b2-kjorl-hns-2021-00892">2</xref>&#x0005d;.</p>
<p>A prescription fitting formula is used to achieve appropriate amplification through certain gain value. Most of the current initial hearing aid fittings for adults are based on the National Acoustic Laboratories Nonlinear 2nd edition (NAL-NL2) formula, a revised version of NAL-NL1 which was developed based on English &#x0005b;<xref ref-type="bibr" rid="b3-kjorl-hns-2021-00892">3</xref>&#x0005d;. After the initial fitting process, the fine-tuning procedure is performed based on the individual&#x02019;s preference. The final satisfied level of hearing aid amplification is considered as the preferred gain &#x0005b;<xref ref-type="bibr" rid="b4-kjorl-hns-2021-00892">4</xref>&#x0005d;. Although fine-tuning may effectively satisfy hearing aid users, the appropriate initial fitting through fitting formula is important &#x0005b;<xref ref-type="bibr" rid="b5-kjorl-hns-2021-00892">5</xref>&#x0005d;.</p>
<p>Adults with mild and moderate HL preferred less overall gain of 3 dB than NAL-NL1 formula in a medium input sound level &#x0005b;<xref ref-type="bibr" rid="b4-kjorl-hns-2021-00892">4</xref>,<xref ref-type="bibr" rid="b6-kjorl-hns-2021-00892">6</xref>&#x0005d;. The NAL-NL2 prescribes more gain in low and high frequencies and less gain in medium frequencies than NAL-NL1 &#x0005b;<xref ref-type="bibr" rid="b3-kjorl-hns-2021-00892">3</xref>&#x0005d;. A study reported at 65 dB and 80 dB SPL, 63% and 50% of participants preferred gain were within 5 dB of the NAL-NL2 prescribed target &#x0005b;<xref ref-type="bibr" rid="b7-kjorl-hns-2021-00892">7</xref>&#x0005d;. However, there is no previous study done on Korean language hearing aid users. The purpose of this study was to investigate the difference between the target gain based on the NAL-NL2 formula and the preferred gain among Korean hearing aid users in South Korea.</p>
</sec>
<sec>
<title>Subjects and Methods</title>
<sec>
<title>Study design</title>
<p>Data were collected between March 2016 and April 2019, 199 monaural hearing aid users from a tertiary health care center in Korea. The participants in the study were first-time hearing aid users with sensorineural HL who were satisfied with their hearing aid for 6 months or more. The preferred gain values were compared with the target gain values based on the NAL-NL2 prescriptive method. This study was performed in accordance with the Helsinki Declaration. The Institutional Review Board approved this study (IRB No. 2021GR0320). The informed consent was waived because this study design is retrospective medical record analysis.</p>
</sec>
<sec>
<title>Fitting procedure</title>
<p>Based on the patient&#x02019;s pure tone audiometry results, the initial setting was done with Target 4.1 (Phonak, Zurich, Switzerland) and Smart Fit 1.4 (ReSound, Ballerup, Denmark) 1.4 programs which were developed based on NAL-NL2 formula. The fine-tuning procedure was usually performed one to two weeks after the initial setting was established. Participants were allowed to undergo the fine-tuning process repeatedly to obtain the most satisfactory sound level for optimum hearing ability. The experienced staff adjusted the gain value in a quiet, controlled room based on the patient&#x02019;s subjective satisfaction within their company&#x02019;s protocol. To achieve a stable level of gain, all the preferred gain values were collected 6 months after initiating the fine-tuning process. The patient&#x02019;s subjective satisfaction was subsequently assessed through the Abbreviate Profile of Hearing Aid Benefit, 66 item self-assessment, disability-based inventory that is used to document the outcome of a hearing aid fitting &#x0005b;<xref ref-type="bibr" rid="b8-kjorl-hns-2021-00892">8</xref>&#x0005d;.</p>
</sec>
<sec>
<title>Data collection</title>
<p>The NAL-NL2 targets prescribe for the input levels of 50, 65, and 80 dB SPL. The data of the gain values were collected when low (50 dB), medium (65 dB), and high (80 dB) input sound levels were administered with low to high frequencies (0.25, 0.5, 1, 2, 4, 8 kHz). Additional data that were collected including age, sex, type of hearing aid, and degree of HL of the hearing aid users. The degree of HL was categorized as mild HL (26-40 dB), moderate HL (41-55 dB), moderately severe HL (56-70 dB), severe HL (71-90 dB), and profound HL (91 dB or more). The three types of hearing aids used by the participants were behind the ear (BTE), receiver in the canal (RIC), and customized type. The customized group included two types of hearing aids: in the ear and completely in canal.</p>
</sec>
<sec>
<title>Exclusion criteria</title>
<p>Exclusion criteria were as follows: less than 10 years of age or more than 90 years of age, profound HL, and history of infectious disease or middle ear surgery.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>A paired t-test was used to compare preferred gain and NAL-NL2 gain. The difference according to hearing aid type was compared using the analysis of variance (ANOVA) t-test. An ANOVA trend analysis was performed to investigate a potential relationship in age. The results were analyzed by IBM SPSS version 20 (IBM Corp., Armonk, NY, USA), and a <italic>p</italic>-value of 0.05 or less was considered significant.</p>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Demographic data</title>
<p>A total of 199 hearing aid users were enrolled in this study. In age distribution, most patients were over 60 years of age (n&#x0003d;142, 71.3%). There was a greater proportion of female participants enrolled in the study (n&#x0003d;116, 58.3%). For the degree of HL, most participants belonged to the moderate (n&#x0003d;87, 43.7%) and moderately severe (n&#x0003d;68, 34.2%) groups. The RIC (n&#x0003d;111, 55.8%) was the most used hearing aid type among the participants, followed by the customized type (n&#x0003d;79, 39.7%), and BTE (n&#x0003d;9, 4.5%) (<xref rid="t1-kjorl-hns-2021-00892" ref-type="table">Table 1</xref>).</p>
</sec>
<sec>
<title>Difference between preferred gain and NAL-NL2</title>
<p>The average preferred gain (17.8&#x000b1;11.7 dB) was higher than the NAL-NL2 gain (15.6&#x000b1;10.4 dB) by 2.2&#x000b1;6.6 dB (95% confidence interval &#x0005b;CI&#x0005d;: 1.30-3.16, <italic>p</italic>&#x0003c;0.001). According to the input sound level, the difference was significant in the high-level (3.9&#x000b1;7.2 dB, 95% CI: 2.89-4.91, <italic>p</italic>&#x0003c;0.001) and medium-level (2.6&#x000b1;7.04 dB, 95% CI: 1.63-3.60, <italic>p</italic>&#x0003c;0.001) input sound (<xref rid="f1-kjorl-hns-2021-00892" ref-type="fig">Fig. 1</xref>). In the frequency response, the preferred gain was statistically higher in all frequencies, except 0.25 kHz and 6 kHz. The difference was largest at 1 kHz (5.6&#x000b1;10.0 dB, 95% CI: 4.78-6.39, <italic>p</italic>&#x0003c; 0.001) followed by 2 kHz (4.7&#x000b1;8.2 dB, 95% CI: 4.094-5.38, <italic>p</italic>&#x0003c;0.001), 0.5 kHz (2.9&#x000b1;8.2 dB, 95% CI: 2.24-3.56, <italic>p</italic>&#x0003c;0.001), and 4 kHz (1.0&#x000b1;0.3 dB, 95% CI: 0.25-1.66, <italic>p</italic>&#x0003c;0.01) (<xref rid="f2-kjorl-hns-2021-00892" ref-type="fig">Fig. 2</xref>).</p>
</sec>
<sec>
<title>Factors associated with preferred gain among hearing aid users</title>
<p>Based on the degree of HL, there was a significant difference between preferred gain and NAL-NL2 gain in moderate HL (2.6&#x000b1; 0.57 dB, 95% CI: 1.42-3.68, <italic>p</italic>&#x0003c;0.01) and moderately severe HL (1.8&#x000b1;0.73 dB, 95% CI: 0.41-3.32, <italic>p</italic>&#x0003c;0.05) (<xref rid="f3-kjorl-hns-2021-00892" ref-type="fig">Fig. 3</xref>).</p>
<p>To investigate the age factor, participants were divided into 60 years old-age group. The pre-existing degree of HL in both groups was not statistically different (58.4 dB vs. 56.2 dB, <italic>p</italic>&#x0003d;0.266). The group of younger participants (20.2&#x000b1;14.0 dB) demanded more gain than the group of older participants (16.9&#x000b1;10.6 dB). In ANOVA trend analysis, there was a tendency of reduced preferred gain with increased age (<italic>p</italic>&#x0003d;0.049).</p>
<p>There were three types of hearing aids: RIC (n&#x0003d;111), customized type (n&#x0003d;79), and BTE (n&#x0003d;9). The pre-existing degree of HL was highest in participants with the BTE type of hearing aid (BTE &#x0005b;62.3 dB&#x0005d;, customized type &#x0005b;60.0 dB&#x0005d;, RIC &#x0005b;54.2 dB&#x0005d;; ANOVA t-test, <italic>p</italic>&#x0003c;0.001). Since the number of BTE was only 9, which is few to classify into one group, the analysis was conducted by integrating with the RIC. The preferred gain of BTE and RIC group was 16.8&#x000b1;13.27 dB and the preferred gain of the customized type group was 20.8&#x000b1;12.25 dB, and the difference was significant (3.91&#x000b1;1.87 dB, 95% CI: -7.8--0.25, <italic>p</italic>&#x0003d;0.036).</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The preferred gain in Korean hearing aid users was significantly higher than the NAL-NL2 gain. This result implies that the target gain based on the NAL-NL2 fitting formula should be increased to reflect this preference among Korean hearing aid users.</p>
<p>The NAL-NL2 formula was invented based on an English-speaking population. The NAL-NL2 also considered language for prescription. For example, tonal languages like Chinese, slightly more low-frequency is prescribed &#x0005b;<xref ref-type="bibr" rid="b3-kjorl-hns-2021-00892">3</xref>&#x0005d;.</p>
<p>Linguistic or acoustic differences between the Korean and English languages may help explain the results obtained in our study. Indeed, a review of the literature confirms the linguistic or acoustic differences between the two languages.</p>
<p>The long-term average speech spectrum (LTSS) shows the average frequency distribution of sound energy in continuous speech. It is used for the evaluation of the hearing instrument&#x02019;s suitability or fitting of hearing aid &#x0005b;<xref ref-type="bibr" rid="b9-kjorl-hns-2021-00892">9</xref>&#x0005d;. In a comparison study of the LTSS of Korean monosyllabic words and sentences and English sentences, there was a significant difference at frequencies of 125, 160, 500, and 4000 Hz (<italic>p</italic>&#x0003c;0.05), but not in other frequencies &#x0005b;<xref ref-type="bibr" rid="b10-kjorl-hns-2021-00892">10</xref>&#x0005d;. The dynamic range (DR) of speech refers to the difference between the minimum and maximum speech levels. The DR for the Korean language was lower than that for the English language at low-frequency bands but larger at mid-frequency bands &#x0005b;<xref ref-type="bibr" rid="b11-kjorl-hns-2021-00892">11</xref>&#x0005d;. The band-importance function (BIF) relates to a value characterizing the relative importance of various frequencies to speech intelligibility &#x0005b;<xref ref-type="bibr" rid="b12-kjorl-hns-2021-00892">12</xref>&#x0005d;. The low-frequency regions below 1 kHz were more important in the Korean language than in the English language &#x0005b;<xref ref-type="bibr" rid="b13-kjorl-hns-2021-00892">13</xref>&#x0005d;. However, it is not yet clear exactly how much these differences affect the preferred gain. The preferred gain was higher than the NAL-NL2 gain at most frequencies except 6 kHz in our study, which is not consistent with previous studies regarding linguistic differences. Further research is needed on the relationship between preferred gains according to differences in LTSS, DR, and BIF.</p>
<p>The tendency for higher gain was found in the group of younger participants. A similar result was found in a previous study, specifically that the group of younger participants preferred greater gain; however, it was not significant (<italic>p</italic>&#x0003d;0.08) &#x0005b;<xref ref-type="bibr" rid="b14-kjorl-hns-2021-00892">14</xref>&#x0005d;. Another study found that children preferred higher gain levels than adults &#x0005b;<xref ref-type="bibr" rid="b15-kjorl-hns-2021-00892">15</xref>&#x0005d;. Age-related emotional, physical, physiological differences may affect the result, but further study is needed.</p>
<p>There were some limitations in this study. The real ear measurements were not performed, and the fine-tuning process followed company&#x02019;s own protocol which could be subjective. Though real ear measurements for fine-tuning of hearing aids were not performed in all cases, the satisfaction of enrolled hearing aid users was proven over the long term through improvement in Abbreviate Profile of Hearing Aid Benefit &#x0005b;<xref ref-type="bibr" rid="b8-kjorl-hns-2021-00892">8</xref>&#x0005d;. The difference due to real ear measurement would have been small since the patient with ear canal deformity, surgical history, and pediatrics were excluded. Even if the fine-tuning process was subjective, it is meaningful because the preferred gain was obtained from the subjectively satisfactory value of the hearing aid users for more than 6 months. Only the monaural hearing aids were analyzed in this study. It is well-known that the binaural loudness summation concept may influence an individual&#x02019;s hearing threshold. Due to binaural summation, the difference in decibels in monoaural hearing aid users is 3-5 dB &#x0005b;<xref ref-type="bibr" rid="b16-kjorl-hns-2021-00892">16</xref>&#x0005d;. For this reason, in NAL-NL2 fitting formula, the monoaural and binaural prescription targets are different. Therefore, the difference between the preferred gain and the NAL-NL2 gain is not due to the monoaural hearing aid. Another limitation is that three types of hearing aids were used. The output power of the hearing aid depends on the characteristics of the hearing aid itself. However, this would not influence the results, because the difference was only determined by the output gain of each hearing aid.</p>
<p>In conclusion, this study analyzed the difference between actual preferred gain and gain value based on the NAL-NL2 formula in Korean hearing aid users. On average, the preferred gain showed a higher gain level than the NAL-NL2 gain. The difference was statistically significant in moderate and moderately severe HL hearing aid users. In the medium or high input level of sound, the gain value should be increased more than the gain based on the NAL-NL2 formula. In terms of frequencies, the higher gain should be administered than the gain obtained from the NAL-NL2 formula in all frequencies except 0.25 and 6 kHz.</p>
</sec>
</body>
<back>
<ack><p>None</p></ack>
<fn-group>
<fn fn-type="participating-researchers"><p><bold>Author Contribution</bold></p>
<p>Conceptualization: Sung-Won Chae. Data curation: Sung-Won Chae. Formal analysis: Jong-Geun Lee. Investigation: Jong-Geun Lee. Methodology: Jae-Jun Song. Project administration: Sung-Won Chae. Resources: Sung-Won Chae. Software: Jae-Min Jeon. Supervision: Sung-Won Chae. Validation: Jae-Min Jeon. Visualization: Jae-Jun Song. Writing&#x02014;original draft: Jong-Geun Lee. Writing&#x02014;review &amp; editing: Jong-Geun Lee.</p></fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-kjorl-hns-2021-00892">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Byrne</surname><given-names>D</given-names></name>
<name><surname>Dillon</surname><given-names>H</given-names></name>
<name><surname>Ching</surname><given-names>T</given-names></name>
<name><surname>Katsch</surname><given-names>R</given-names></name>
<name><surname>Keidser</surname><given-names>G</given-names></name>
</person-group>
<article-title>NAL-NL1 procedure for fitting nonlinear hearing aids: Characteristics and comparisons with other procedures</article-title>
<source>J Am Acad Audiol</source>
<year>2001</year>
<volume>12</volume>
<issue>1</issue>
<fpage>37</fpage>
<lpage>51</lpage>
</element-citation></ref>
<ref id="b2-kjorl-hns-2021-00892">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ching</surname><given-names>TY</given-names></name>
<name><surname>Dillon</surname><given-names>H</given-names></name>
<name><surname>Katsch</surname><given-names>R</given-names></name>
<name><surname>Byrne</surname><given-names>D</given-names></name>
</person-group>
<article-title>Maximizing effective audibility in hearing aid fitting</article-title>
<source>Ear Hear</source>
<year>2001</year>
<volume>22</volume>
<issue>3</issue>
<fpage>212</fpage>
<lpage>24</lpage>
</element-citation></ref>
<ref id="b3-kjorl-hns-2021-00892">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Keidser</surname><given-names>G</given-names></name>
<name><surname>Dillon</surname><given-names>H</given-names></name>
<name><surname>Flax</surname><given-names>M</given-names></name>
<name><surname>Ching</surname><given-names>T</given-names></name>
<name><surname>Brewer</surname><given-names>S</given-names></name>
</person-group>
<article-title>The NAL-NL2 prescription procedure</article-title>
<source>Audiol Res</source>
<year>2011</year>
<volume>1</volume>
<issue>1</issue>
<elocation-id>e24</elocation-id>
</element-citation></ref>
<ref id="b4-kjorl-hns-2021-00892">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Keidser</surname><given-names>G</given-names></name>
<name><surname>O&#x02019;Brien</surname><given-names>A</given-names></name>
<name><surname>Carter</surname><given-names>L</given-names></name>
<name><surname>McLelland</surname><given-names>M</given-names></name>
<name><surname>Yeend</surname><given-names>I</given-names></name>
</person-group>
<article-title>Variation in preferred gain with experience for hearing-aid users</article-title>
<source>Int J Audiol</source>
<year>2008</year>
<volume>47</volume>
<issue>10</issue>
<fpage>621</fpage>
<lpage>35</lpage>
</element-citation></ref>
<ref id="b5-kjorl-hns-2021-00892">
<label>5</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Mueller</surname><given-names>HG</given-names></name>
<name><surname>Hawkins</surname><given-names>DB</given-names></name>
<name><surname>Northern</surname><given-names>JL</given-names></name>
</person-group>
<source>Probe microphone measurements: Hearing aid selection and assessment</source>
<publisher-loc>San Diego</publisher-loc>
<publisher-name>Singular</publisher-name>
<year>1992</year>
</element-citation></ref>
<ref id="b6-kjorl-hns-2021-00892">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Boymans</surname><given-names>M</given-names></name>
<name><surname>Dreschler</surname><given-names>WA</given-names></name>
</person-group>
<article-title>Audiologist-driven versus patient-driven fine tuning of hearing instruments</article-title>
<source>Trends Amplif</source>
<year>2012</year>
<volume>16</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>58</lpage>
</element-citation></ref>
<ref id="b7-kjorl-hns-2021-00892">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>English</surname><given-names>R</given-names></name>
<name><surname>Plant</surname><given-names>K</given-names></name>
<name><surname>Maciejcz yk</surname><given-names>M</given-names></name>
<name><surname>Cowan</surname><given-names>R</given-names></name>
</person-group>
<article-title>Fit ti ng recommendations and clinical benefit associated with use of the NAL-NL2 hearing-aid prescription in nucleus cochlear implant recipients</article-title>
<source>Int J Audiol</source>
<year>2016</year>
<volume>55 Suppl 2</volume>
<issue>1</issue>
<fpage>S45</fpage>
<lpage>50</lpage>
</element-citation></ref>
<ref id="b8-kjorl-hns-2021-00892">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cox</surname><given-names>RM</given-names></name>
<name><surname>Alexander</surname><given-names>GC</given-names></name>
</person-group>
<article-title>The abbreviated profile of hearing aid benefit</article-title>
<source>Ear Hear</source>
<year>1995</year>
<volume>16</volume>
<issue>2</issue>
<fpage>176</fpage>
<lpage>86</lpage>
</element-citation></ref>
<ref id="b9-kjorl-hns-2021-00892">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pavlovic</surname><given-names>CV</given-names></name>
</person-group>
<article-title>Speech spectrum considerations and speech intelligibility predictions in hearing aid evaluations</article-title>
<source>J Speech Hear Disord</source>
<year>1989</year>
<volume>54</volume>
<issue>1</issue>
<fpage>3</fpage>
<lpage>8</lpage>
</element-citation></ref>
<ref id="b10-kjorl-hns-2021-00892">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jin</surname><given-names>IK</given-names></name>
<name><surname>Lee</surname><given-names>JH</given-names></name>
</person-group>
<article-title>A comparison of long-term average speech spectrum (LTASS) among Korean monosllyabic words, sentences, and English sentences</article-title>
<source>Audiology</source>
<year>2010</year>
<volume>6</volume>
<issue>2</issue>
<fpage>164</fpage>
<lpage>72</lpage>
</element-citation></ref>
<ref id="b11-kjorl-hns-2021-00892">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jin</surname><given-names>IK</given-names></name>
<name><surname>Kates</surname><given-names>JM</given-names></name>
<name><surname>Arehart</surname><given-names>KH</given-names></name>
</person-group>
<article-title>Dynamic range for speech materials in Korean, English, and Mandarin: A cross-language comparison</article-title>
<source>J Speech Lang Hear Res</source>
<year>2014</year>
<volume>57</volume>
<issue>5</issue>
<fpage>2024</fpage>
<lpage>30</lpage>
</element-citation></ref>
<ref id="b12-kjorl-hns-2021-00892">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bosen</surname><given-names>AK</given-names></name>
<name><surname>Chatterjee</surname><given-names>M</given-names></name>
</person-group>
<article-title>Band importance functions of listeners with cochlear implants using clinical maps</article-title>
<source>J Acoust Soc Am</source>
<year>2016</year>
<volume>140</volume>
<issue>5</issue>
<fpage>3718</fpage>
</element-citation></ref>
<ref id="b13-kjorl-hns-2021-00892">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jin</surname><given-names>IK</given-names></name>
<name><surname>Lee</surname><given-names>J</given-names></name>
<name><surname>Lee</surname><given-names>K</given-names></name>
<name><surname>Kim</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>D</given-names></name>
<name><surname>Sohn</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>The band-importance function for the Korean standard sentence lists for adults</article-title>
<source>J Audiol Otol</source>
<year>2016</year>
<volume>20</volume>
<issue>2</issue>
<fpage>80</fpage>
<lpage>4</lpage>
</element-citation></ref>
<ref id="b14-kjorl-hns-2021-00892">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Keidser</surname><given-names>G</given-names></name>
<name><surname>Dillon</surname><given-names>H</given-names></name>
<name><surname>Carter</surname><given-names>L</given-names></name>
<name><surname>O&#x02019;Brien</surname><given-names>A</given-names></name>
</person-group>
<article-title>NAL-NL2 empirical adjustments</article-title>
<source>Trends Amplif</source>
<year>2012</year>
<volume>16</volume>
<issue>4</issue>
<fpage>211</fpage>
<lpage>23</lpage>
</element-citation></ref>
<ref id="b15-kjorl-hns-2021-00892">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ching</surname><given-names>TY</given-names></name>
<name><surname>Scollie</surname><given-names>SD</given-names></name>
<name><surname>Dillon</surname><given-names>H</given-names></name>
<name><surname>Seewald</surname><given-names>R</given-names></name>
</person-group>
<article-title>A cross-over, double-blind comparison of the NAL-NL1 and the DSL v4.1 prescriptions for children with mild to moderately severe hearing loss</article-title>
<source>Int J Audiol</source>
<year>2010</year>
<volume>49 Suppl 1</volume>
<fpage>S4</fpage>
<lpage>15</lpage>
</element-citation></ref>
<ref id="b16-kjorl-hns-2021-00892">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dermody</surname><given-names>P</given-names></name>
<name><surname>Byrne</surname><given-names>D</given-names></name>
</person-group>
<article-title>Loudness summation with binaural hearing aids</article-title>
<source>Scand Audiol</source>
<year>1975</year>
<volume>4</volume>
<issue>1</issue>
<fpage>23</fpage>
<lpage>8</lpage>
</element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Table</title>
<fig id="f1-kjorl-hns-2021-00892" position="float">
<label>Fig. 1.</label><caption><p>Comparison of preferred gain and NAL-NL2 gain data by level of sound. There is a significant difference in medium-input sound level and high-input sound level groups. Paired t-test was used to determine significance. <sup>&#x02021;</sup><italic>p</italic>&lt;0.001. NAL-NL2, National Acoustic Laboratories Non-Linear 2nd edition.</p></caption>
<graphic xlink:href="kjorl-hns-2021-00892f1.tif"/></fig>
<fig id="f2-kjorl-hns-2021-00892" position="float">
<label>Fig. 2.</label><caption><p>Comparison of preferred gain and NAL-NL2 gain data by frequency. There is a significant difference in 0.5 kHz, 1 kHz, 2 kHz, and 4 kHz groups. <sup>&#x02020;</sup><italic>p</italic>&lt;0.01; <sup>&#x02021;</sup><italic>p</italic>&lt;0.001. NAL-NL2, National Acoustic Laboratories Non-Linear 2nd edition.</p></caption>
<graphic xlink:href="kjorl-hns-2021-00892f2.tif"/></fig>
<fig id="f3-kjorl-hns-2021-00892" position="float">
<label>Fig. 3.</label><caption><p>Comparison of preferred gain and NAL-NL2 gain data by degree of HL. There is a significant difference in moderate HL and moderately severe HL groups. <sup>*</sup><italic>p</italic>&lt;0.05; <sup>&#x02020;</sup><italic>p</italic>&lt;0.01. NAL-NL2, National Acoustic Laboratories Non-Linear 2nd edition; HL, hearingloss.</p></caption>
<graphic xlink:href="kjorl-hns-2021-00892f3.tif"/></fig>
<table-wrap id="t1-kjorl-hns-2021-00892" position="float">
<label>Table 1.</label>
<caption><p>Levels of hearing ability by demographics and types of hearing aid (n=199)</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="center" valign="middle">Degree of hearing loss</th>
<th align="center" valign="middle">Mild</th>
<th align="center" valign="middle">Moderate</th>
<th align="center" valign="middle">Moderately severe</th>
<th align="center" valign="middle">Severe</th>
<th align="center" valign="middle">Total</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Sex</td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;Male</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">28</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">83</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;Female</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">40</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">116</td>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;10-19</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">11</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;20-29</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;30-39</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;40-49</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">10</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;50-59</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">19</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;60-69</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">22</td>
<td valign="top" align="center">19</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">49</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;70-79</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">22</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">52</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;80-89</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">20</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">41</td>
</tr>
<tr>
<td valign="top" align="left">Type of hearing aid</td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
<td valign="top" align="center"></td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;BTE and RIC</td>
<td valign="top" align="center">11</td>
<td valign="top" align="center">58</td>
<td valign="top" align="center">37</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">120</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;Custom</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">31</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">79</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>BTE, behind the ear; RIC, receiver in the canal</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>